EV/EBITDA spoločnosti Panbela Therapeutics
Aká je hodnota metriky EV/EBITDA spoločnosti Panbela Therapeutics?
Hodnota metriky EV/EBITDA spoločnosti Panbela Therapeutics Inc. je N/A
Aká je definícia metriky EV/EBITDA?
EV/EBITDA je podniková hodnota vydelená EBITDA (zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie). Meria nákladnosť akcie a používa sa na porovnávanie spoločností medzi sebou častejšie ako P/E ratio. Meria cenu akú investor zaplatí za pohyb hotovosti v spoločnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Panbela Therapeutics
Čomu sa venuje spoločnosť Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy s metrikou ev/ebitda podobnou spoločnosti Panbela Therapeutics
- Hodnota metriky EV/EBITDA spoločnosti Guild Esports Plc je N/A
- Hodnota metriky EV/EBITDA spoločnosti Delta Drone SA je N/A
- Hodnota metriky EV/EBITDA spoločnosti Canaccord Genuity je N/A
- Hodnota metriky EV/EBITDA spoločnosti Lordstown Motors je N/A
- Hodnota metriky EV/EBITDA spoločnosti Tesla Exploration je N/A
- Hodnota metriky EV/EBITDA spoločnosti DigiCrypts Blockchain Solutions je N/A
- Hodnota metriky EV/EBITDA spoločnosti Panbela Therapeutics je N/A
- Hodnota metriky EV/EBITDA spoločnosti Hapbee Technologies je N/A
- Hodnota metriky EV/EBITDA spoločnosti China Parenting Network je N/A
- Hodnota metriky EV/EBITDA spoločnosti X4 Pharmaceuticals je N/A
- Hodnota metriky EV/EBITDA spoločnosti Delta Drone SA je N/A
- Hodnota metriky EV/EBITDA spoločnosti Diablo Resources Ltd je N/A
- Hodnota metriky EV/EBITDA spoločnosti cbdMD Inc je N/A